Barbara Gayle Duncan, CFO at Intercept Pharma, holds 24.89K shares in Intercept Pharma (Ticker: ICPT), holds ― shares in Adaptimmune Therapeutics (Ticker: ADAP), holds 0.00 shares in Innoviva (Ticker: INVA). Most recently, Barbara Gayle Duncan Sold ― shares of Intercept Pharma on Oct 05, 2016 for an estimated value of 23.99K.
What was Barbara Gayle Duncan’s latest transaction?
Barbara Gayle Duncan latest transaction was an Informative Sell of $23.99K.
What was Barbara Gayle Duncan's most profitable transaction?
Barbara Gayle Duncan’s most profitable transaction was an Informative Sell of ICPT stock on April 1, 2015. The return on the trade was 52.70%.
What is Barbara Gayle Duncan's role in Intercept Pharma?
Barbara Gayle Duncan's role in Intercept Pharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.